OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
April 30, 2013
Just about every federal program and affected interest group is pressing for relief from the 8% across-the-board cuts in funding imposed by the budget sequestration mandate.
April 17, 2013
The Obama administration’s budget plan for fiscal year 2014 apparently assumes that the pharmaceutical industry can support Medicare and other health programs through changes in drug coverage and payments.
FDA has come down on the side of reducing abuse of opioid medications, over encouraging wider availability of low-cost painkiller meds.
April 02, 2013
Opioid abuse generates calls for efforts to curb distribution, develop abuse-resistant formulations.
Latest news about compound pharmacies, biosimilars, prescription drug purchases, and other regulatory topics.
March 13, 2013
After less than a year on the job, the head of FDA’s Office of Generic Drugs (OGD) has announced his departure, a sign that all is not well with plans for major organizational changes at the Center for Drug Evaluation and Research (CDER).